Bourzikat, Otmane; El Abbouchi, Abdelmoula; Ghammaz, Hamza; El Brahmi, Nabil; El Fahime, Elmostfa; Paris, Arnaud; Daniellou, Richard; Suzenet, Franck; Guillaumet, Gerald; El Kazzouli, Said published the artcile< Synthesis, Anticancer Activities and Molecular Docking Studies of a Novel Class of 2-Phenyl-5,6,7,8-tetrahydroimidazo[1,2-b]pyridazine Derivatives Bearing Sulfonamides>, Reference of 22952-32-5, the main research area is arylsulfonyl tetrahydroimidazopyridazine preparation anticancer human mol docking SAR; sulfonyl chloride phenyl tetrahydroimidazopyridazine sulfonylation; 2-phenyl-5,6,7,8-tetrahydroimidazo [1,2-b]pyridazine; anticancer activity; human cancer cell lines; sulfonamides.
New 2-phenyl-5-(arylsulfonyl)-7,8-dihydro-6H-imidazo[1,2-b]pyridazines I [R = 4-MeC6H4, 4-F3CC6H4, 1-naphthyl, etc.] were synthesized via sulfonylation of 2-phenyl-5,6,7,8-tetrahydroimidazo[1,2-b]pyridazine using sulfonyl chlorides. The structures of these derivatives I were elucidated by 1H NMR, 13C NMR, IR and high-resolution mass spectrometry for further characterization and were further evaluated for their anticancer activities. The anticancer activities of compounds I were evaluated against five human cancer cell lines, including A-549, Hs-683, MCF-7, SK-MEL-28 and B16-F10 cell lines with 5-fluorouracil and etoposide as reference drugs. Among the tested compounds, I [R = 5-Cl-2-OMeC6H3, 4-F3CC6H4] exhibited excellent activities in the same range of the pos. controls, 5-fluorouracil and etoposide, against MCF-7 and SK-MEL-28 cancer cell lines, with IC50 values ranging from 1 to 10 μM. The mol. docking studies of compounds, I [R = 5-Cl-2-OMeC6H3, 4-F3CC6H4] showed a strong binding with some kinases, which were linked to MCF-7 and SK-MEL-28 cancer cell lines.
Molecules published new progress about Antitumor agents. 22952-32-5 belongs to class chlorides-buliding-blocks, and the molecular formula is C7H6Cl2O3S, Reference of 22952-32-5.
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics